Literature DB >> 30951662

Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation.

Sandra Varum1, Arianna Baggiolini1, Luis Zurkirchen1, Zeynep Kalender Atak2, Claudio Cantù3, Elisa Marzorati1, Raphaël Bossart1, Jasper Wouters2, Jessica Häusel1, Eylül Tuncer1, Daniel Zingg1, Dominiek Veen1, Nessy John1, Marcel Balz1, Mitchell P Levesque4, Konrad Basler3, Stein Aerts2, Nicola Zamboni5, Reinhard Dummer4, Lukas Sommer6.   

Abstract

Increasing evidence suggests that cancer cells highjack developmental programs for disease initiation and progression. Melanoma arises from melanocytes that originate during development from neural crest stem cells (NCSCs). Here, we identified the transcription factor Yin Yang 1 (Yy1) as an NCSCs regulator. Conditional deletion of Yy1 in NCSCs resulted in stage-dependent hypoplasia of all major neural crest derivatives due to decreased proliferation and increased cell death. Moreover, conditional ablation of one Yy1 allele in a melanoma mouse model prevented tumorigenesis, indicating a particular susceptibility of melanoma cells to reduced Yy1 levels. Combined RNA sequencing (RNA-seq), chromatin immunoprecipitation (ChIP)-seq, and untargeted metabolomics demonstrated that YY1 governs multiple metabolic pathways and protein synthesis in both NCSCs and melanoma. In addition to directly regulating a metabolic gene set, YY1 can act upstream of MITF/c-MYC as part of a gene regulatory network controlling metabolism. Thus, both NCSC development and melanoma formation depend on an intricate YY1-controlled metabolic program.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  YY1; development; melanoma; metabolism; neural crest; protein synthesis; tumor initiation

Mesh:

Substances:

Year:  2019        PMID: 30951662     DOI: 10.1016/j.stem.2019.03.011

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  16 in total

Review 1.  Neural crest lineage analysis: from past to future trajectory.

Authors:  Weiyi Tang; Marianne E Bronner
Journal:  Development       Date:  2020-10-23       Impact factor: 6.868

2.  Developmental chromatin programs determine oncogenic competence in melanoma.

Authors:  Arianna Baggiolini; Scott J Callahan; Lorenz Studer; Richard M White; Emily Montal; Joshua M Weiss; Tuan Trieu; Mohita M Tagore; Sam E Tischfield; Ryan M Walsh; Shruthy Suresh; Yujie Fan; Nathaniel R Campbell; Sarah C Perlee; Nathalie Saurat; Miranda V Hunter; Theresa Simon-Vermot; Ting-Hsiang Huang; Yilun Ma; Travis Hollmann; Satish K Tickoo; Barry S Taylor; Ekta Khurana; Richard P Koche
Journal:  Science       Date:  2021-09-03       Impact factor: 63.714

3.  Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells.

Authors:  Zhixin Qiu; Linjie Zhao; Jia Z Shen; Zhengyu Liang; Qiulian Wu; Kailin Yang; Lihua Min; Ryan C Gimple; Qiyuan Yang; Shruti Bhargava; Chunyu Jin; Cheryl Kim; Denise Hinz; Deobrat Dixit; Jean A Bernatchez; Briana C Prager; Guoxin Zhang; Zhen Dong; Deguan Lv; Xujun Wang; Leo J Y Kim; Zhe Zhu; Katherine A Jones; Ye Zheng; Xiuxing Wang; Jair L Siqueira-Neto; Lukas Chavez; Xiang-Dong Fu; Charles Spruck; Jeremy N Rich
Journal:  Cancer Discov       Date:  2021-10-06       Impact factor: 38.272

4.  Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.

Authors:  Johanna Diener; Arianna Baggiolini; Mattias Pernebrink; Damian Dalcher; Luigi Lerra; Phil F Cheng; Sandra Varum; Jessica Häusel; Salome Stierli; Mathias Treier; Lorenz Studer; Konrad Basler; Mitchell P Levesque; Reinhard Dummer; Raffaella Santoro; Claudio Cantù; Lukas Sommer
Journal:  Nat Commun       Date:  2021-08-20       Impact factor: 14.919

5.  Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.

Authors:  Jana Travnickova; Sonia Wojciechowska; Ava Khamseh; Philippe Gautier; Daniel V Brown; Thomas Lefevre; Alessandro Brombin; Ailith Ewing; Amy Capper; Michaela Spitzer; Ramile Dilshat; Colin A Semple; Marie E Mathers; James A Lister; Eiríkur Steingrimsson; Thierry Voet; Chris P Ponting; E Elizabeth Patton
Journal:  Cancer Res       Date:  2019-10-03       Impact factor: 12.701

Review 6.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

7.  Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia.

Authors:  Joan So; Alexander C Lewis; Lorey K Smith; Kym Stanley; Rheana Franich; David Yoannidis; Lizzy Pijpers; Pilar Dominguez; Simon J Hogg; Stephin J Vervoort; Fiona C Brown; Ricky W Johnstone; Gabrielle McDonald; Danielle B Ulanet; Josh Murtie; Emily Gruber; Lev M Kats
Journal:  EMBO Mol Med       Date:  2022-05-06       Impact factor: 14.260

Review 8.  Reemergence of neural crest stem cell-like states in melanoma during disease progression and treatment.

Authors:  Johanna Diener; Lukas Sommer
Journal:  Stem Cells Transl Med       Date:  2020-12-01       Impact factor: 6.940

Review 9.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

10.  FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State.

Authors:  Athanasios Blanas; Anouk Zaal; Irene van der Haar Àvila; Maxime Kempers; Laura Kruijssen; Mike de Kok; Marko A Popovic; Joost C van der Horst; Sandra J van Vliet
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.